Vitiligo Lesions Improved after Oral Cyclosporine in a Patient with Vitiligo and Atopic Dermatitis.
- Author:
Yunseok CHOI
1
;
Won Suk LIM
;
Sang Yun JIN
;
Joon Ho LEE
;
Seung Ho LEE
;
Ai Young LEE
Author Information
1. Department of Dermatology, Dongguk University Ilsan Hospital, College of Medicine, Dongguk University, Goyang, Korea. lay5604@naver.com
- Publication Type:Case Report
- Keywords:
Atopic dermatitis;
Cyclosporine;
Vitiligo
- MeSH:
Adrenal Cortex Hormones;
Cyclosporine;
Dermatitis, Atopic;
Humans;
Immunologic Factors;
Phototherapy;
Pigmentation;
Vitiligo
- From:Korean Journal of Dermatology
2012;50(2):159-162
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Vitiligo is an acquired cutaneous disorder of pigmentation with no definite etiology. Although there are a number of treatment modalities including phototherapy, topical corticosteroids and topical immunomodulators, few studies on the effect of systemic cyclosporine for the treatment of vitiligo have been conducted. We have experienced the improvement of vitiligo lesions after 8 months of systemic administration of cyclosporine (2.5~3.3 mg/kg/day) in a patient with vitiligo and atopic dermatitis. We believe this case report warrants further investigations of cyclosporine for the treatment of vitiligo in terms of mechanisms and clinical outcomes as well.
